1993
DOI: 10.1128/jvi.67.3.1461-1471.1993
|View full text |Cite
|
Sign up to set email alerts
|

Two mechanisms of soluble CD4 (sCD4)-mediated inhibition of human immunodeficiency virus type 1 (HIV-1) infectivity and their relation to primary HIV-1 isolates with reduced sensitivity to sCD4

Abstract: Two assays for measuring inhibition of human immunodeficiency virus type 1 (HIV-1) infection by soluble CD4 (sCD4) are described. Experiments in which sCD4, HIV-1, and cell concentrations and sequence of combination, noninfectious/infectious particle ratio, and temperature were varied produced results that support the conclusion that sCD4 inhibits HIV-1 infection by two mechanisms: reversible blockage of receptor binding and irreversible inactivation of infectivity. Fresh isolates obtained from HIV-1-infected … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

5
52
0
1

Year Published

1994
1994
2008
2008

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 88 publications
(58 citation statements)
references
References 41 publications
5
52
0
1
Order By: Relevance
“…An interpretation of these data is that the reaction between cell-surface CD4 and the envelope glycoprotein complex of primary viruses is relatively inefficient and rate limiting for infection. This would be consistent with prior results obtained from studies of the interactions of sCD4 with primary viruses (18,21,26,33).…”
Section: -supporting
confidence: 92%
See 2 more Smart Citations
“…An interpretation of these data is that the reaction between cell-surface CD4 and the envelope glycoprotein complex of primary viruses is relatively inefficient and rate limiting for infection. This would be consistent with prior results obtained from studies of the interactions of sCD4 with primary viruses (18,21,26,33).…”
Section: -supporting
confidence: 92%
“…We suggest that what we have observed in this study with molecularly cloned viruses, and previously with uncloned primary and T-cell line-adapted viruses (18,28), reflects functional differences between the envelope glycoproteins of macrophage-tropic, primary HIV-1 viruses and those adapted to growth in T-cell lines (15). It has been known for several years that primary HIV-1 isolates grown only in PBMC, or plasma virus ex vivo, resist neutralization by sCD4, in contrast to viruses adapted to growth in transformed T-cell lines (3,4,7,18,21,26,33). All primary viruses we have tested shed gpl20 more rapidly at 4°C than at 37°C.…”
Section: -mentioning
confidence: 97%
See 1 more Smart Citation
“…The interaction of the envelope glycoproteins of different HIV-1 isolates with the CD4 viral receptor appears to differ, since primary viruses are resistant to a soluble form of CD4 (sCD4), in contrast to laboratory-passaged isolates (18,28). Differences in the affinity of sCD4, apparent only in the context of the oligomeric envelope glycoproteins, for primary and laboratory-passaged HIV-1 isolates have been suggested as an explanation of this relative resistance (5,32,39,41,45,58,60).…”
mentioning
confidence: 99%
“…Despite the optimism, however, it turned out that CD4based decoys simply did not have the clout required to keep HIV in check. It was quickly realized that the neutralizing potency of sCD4 was preferentially greater for lab adapted strains of HIV than for the field isolates of this virus [28,29]. The mechanism for neutralization by the decoy required induced gp120 shedding that turned out to be much more demanding for the field isolates [30].…”
Section: Anti-viral Decoysmentioning
confidence: 99%